Chronic morphine exposure causes pronounced virus replication in cerebral compartment and accelerated onset of AIDS in SIV/SHIV-infected Indian rhesus macaques

Rakesh Kumar, Suheydi Orsoni, Lisa Norman, Ashish S. Verma, Grissell Tirado, Luis D. Giavedoni, Silvija Staprans, Gregory M. Miller, Shilpa J. Buch, Anil Kumar

Research output: Contribution to journalArticle

56 Citations (Scopus)

Abstract

Six morphine-exposed and 3 control male Indian rhesus macaques were intravenously inoculated with mixture of SHIVKU, SHIV89.6P and SIV/17E-Fr. These animals were followed for a period of 56 weeks in order to determine CD4 and CD8 profile, viral loads in plasma and cerebrospinal fluid (CSF), relative distribution of 3 pathogenic viruses in blood and brain, binding as well neutralizing antibody levels and cellular immune responses. Both morphine-exposed and control macaques showed a precipitous loss of CD4+ T cells; control animals, however, showed a greater tendency to recover these cells than did their morphine-exposed counterparts. The plasma and CSF viral loads were significantly higher in morphine-exposed group than those in the control group. Four morphine-exposed animals succumbed to SIV/SHIV-induced AIDS at week 18, 19, 20 and 51; post-infection with neurological disorders was found in 3 of the 4 animals. At the end of the 56-week observation period, 2 morphine-exposed and 3 control animals were still alive. All 3 viruses replicated in the blood of both morphine-exposed and control macaques, but the cerebral compartment showed a selection phenomenon; only SIV/17E-Fr and SHIVKU successfully crossed the blood brain barrier (BBB). The morphine-exposed macaques further favored viral migration through the blood brain barrier (BBB). SIV/17E-Fr crossed the BBB within 2 weeks in both morphine-exposed and control macaques, whereas SHIVKU crossed the BBB more rapidly in morphine-exposed than in control macaques. Three morphine-exposed macaques (euthanized at weeks 18, 19 and 20) did not develop cellular or humoral immune responses, whereas the other 3 morphine-exposed and 3 control macaques developed both cellular and humoral immune responses.

Original languageEnglish (US)
Pages (from-to)192-206
Number of pages15
JournalVirology
Volume354
Issue number1
DOIs
StatePublished - Oct 10 2006

Fingerprint

Virus Replication
Macaca mulatta
Morphine
Acquired Immunodeficiency Syndrome
Macaca
Blood-Brain Barrier
Cellular Immunity
Humoral Immunity
Viral Load
Cerebrospinal Fluid
Viruses
Neutralizing Antibodies
Nervous System Diseases
Observation
T-Lymphocytes

Keywords

  • AIDS
  • Indian rhesus macaques
  • Morphine
  • SHIV
  • SIV

ASJC Scopus subject areas

  • Virology

Cite this

Chronic morphine exposure causes pronounced virus replication in cerebral compartment and accelerated onset of AIDS in SIV/SHIV-infected Indian rhesus macaques. / Kumar, Rakesh; Orsoni, Suheydi; Norman, Lisa; Verma, Ashish S.; Tirado, Grissell; Giavedoni, Luis D.; Staprans, Silvija; Miller, Gregory M.; Buch, Shilpa J.; Kumar, Anil.

In: Virology, Vol. 354, No. 1, 10.10.2006, p. 192-206.

Research output: Contribution to journalArticle

Kumar, Rakesh ; Orsoni, Suheydi ; Norman, Lisa ; Verma, Ashish S. ; Tirado, Grissell ; Giavedoni, Luis D. ; Staprans, Silvija ; Miller, Gregory M. ; Buch, Shilpa J. ; Kumar, Anil. / Chronic morphine exposure causes pronounced virus replication in cerebral compartment and accelerated onset of AIDS in SIV/SHIV-infected Indian rhesus macaques. In: Virology. 2006 ; Vol. 354, No. 1. pp. 192-206.
@article{d9a85a292b9d44f7a7a061eee0031d35,
title = "Chronic morphine exposure causes pronounced virus replication in cerebral compartment and accelerated onset of AIDS in SIV/SHIV-infected Indian rhesus macaques",
abstract = "Six morphine-exposed and 3 control male Indian rhesus macaques were intravenously inoculated with mixture of SHIVKU, SHIV89.6P and SIV/17E-Fr. These animals were followed for a period of 56 weeks in order to determine CD4 and CD8 profile, viral loads in plasma and cerebrospinal fluid (CSF), relative distribution of 3 pathogenic viruses in blood and brain, binding as well neutralizing antibody levels and cellular immune responses. Both morphine-exposed and control macaques showed a precipitous loss of CD4+ T cells; control animals, however, showed a greater tendency to recover these cells than did their morphine-exposed counterparts. The plasma and CSF viral loads were significantly higher in morphine-exposed group than those in the control group. Four morphine-exposed animals succumbed to SIV/SHIV-induced AIDS at week 18, 19, 20 and 51; post-infection with neurological disorders was found in 3 of the 4 animals. At the end of the 56-week observation period, 2 morphine-exposed and 3 control animals were still alive. All 3 viruses replicated in the blood of both morphine-exposed and control macaques, but the cerebral compartment showed a selection phenomenon; only SIV/17E-Fr and SHIVKU successfully crossed the blood brain barrier (BBB). The morphine-exposed macaques further favored viral migration through the blood brain barrier (BBB). SIV/17E-Fr crossed the BBB within 2 weeks in both morphine-exposed and control macaques, whereas SHIVKU crossed the BBB more rapidly in morphine-exposed than in control macaques. Three morphine-exposed macaques (euthanized at weeks 18, 19 and 20) did not develop cellular or humoral immune responses, whereas the other 3 morphine-exposed and 3 control macaques developed both cellular and humoral immune responses.",
keywords = "AIDS, Indian rhesus macaques, Morphine, SHIV, SIV",
author = "Rakesh Kumar and Suheydi Orsoni and Lisa Norman and Verma, {Ashish S.} and Grissell Tirado and Giavedoni, {Luis D.} and Silvija Staprans and Miller, {Gregory M.} and Buch, {Shilpa J.} and Anil Kumar",
year = "2006",
month = "10",
day = "10",
doi = "10.1016/j.virol.2006.06.020",
language = "English (US)",
volume = "354",
pages = "192--206",
journal = "Virology",
issn = "0042-6822",
publisher = "Academic Press Inc.",
number = "1",

}

TY - JOUR

T1 - Chronic morphine exposure causes pronounced virus replication in cerebral compartment and accelerated onset of AIDS in SIV/SHIV-infected Indian rhesus macaques

AU - Kumar, Rakesh

AU - Orsoni, Suheydi

AU - Norman, Lisa

AU - Verma, Ashish S.

AU - Tirado, Grissell

AU - Giavedoni, Luis D.

AU - Staprans, Silvija

AU - Miller, Gregory M.

AU - Buch, Shilpa J.

AU - Kumar, Anil

PY - 2006/10/10

Y1 - 2006/10/10

N2 - Six morphine-exposed and 3 control male Indian rhesus macaques were intravenously inoculated with mixture of SHIVKU, SHIV89.6P and SIV/17E-Fr. These animals were followed for a period of 56 weeks in order to determine CD4 and CD8 profile, viral loads in plasma and cerebrospinal fluid (CSF), relative distribution of 3 pathogenic viruses in blood and brain, binding as well neutralizing antibody levels and cellular immune responses. Both morphine-exposed and control macaques showed a precipitous loss of CD4+ T cells; control animals, however, showed a greater tendency to recover these cells than did their morphine-exposed counterparts. The plasma and CSF viral loads were significantly higher in morphine-exposed group than those in the control group. Four morphine-exposed animals succumbed to SIV/SHIV-induced AIDS at week 18, 19, 20 and 51; post-infection with neurological disorders was found in 3 of the 4 animals. At the end of the 56-week observation period, 2 morphine-exposed and 3 control animals were still alive. All 3 viruses replicated in the blood of both morphine-exposed and control macaques, but the cerebral compartment showed a selection phenomenon; only SIV/17E-Fr and SHIVKU successfully crossed the blood brain barrier (BBB). The morphine-exposed macaques further favored viral migration through the blood brain barrier (BBB). SIV/17E-Fr crossed the BBB within 2 weeks in both morphine-exposed and control macaques, whereas SHIVKU crossed the BBB more rapidly in morphine-exposed than in control macaques. Three morphine-exposed macaques (euthanized at weeks 18, 19 and 20) did not develop cellular or humoral immune responses, whereas the other 3 morphine-exposed and 3 control macaques developed both cellular and humoral immune responses.

AB - Six morphine-exposed and 3 control male Indian rhesus macaques were intravenously inoculated with mixture of SHIVKU, SHIV89.6P and SIV/17E-Fr. These animals were followed for a period of 56 weeks in order to determine CD4 and CD8 profile, viral loads in plasma and cerebrospinal fluid (CSF), relative distribution of 3 pathogenic viruses in blood and brain, binding as well neutralizing antibody levels and cellular immune responses. Both morphine-exposed and control macaques showed a precipitous loss of CD4+ T cells; control animals, however, showed a greater tendency to recover these cells than did their morphine-exposed counterparts. The plasma and CSF viral loads were significantly higher in morphine-exposed group than those in the control group. Four morphine-exposed animals succumbed to SIV/SHIV-induced AIDS at week 18, 19, 20 and 51; post-infection with neurological disorders was found in 3 of the 4 animals. At the end of the 56-week observation period, 2 morphine-exposed and 3 control animals were still alive. All 3 viruses replicated in the blood of both morphine-exposed and control macaques, but the cerebral compartment showed a selection phenomenon; only SIV/17E-Fr and SHIVKU successfully crossed the blood brain barrier (BBB). The morphine-exposed macaques further favored viral migration through the blood brain barrier (BBB). SIV/17E-Fr crossed the BBB within 2 weeks in both morphine-exposed and control macaques, whereas SHIVKU crossed the BBB more rapidly in morphine-exposed than in control macaques. Three morphine-exposed macaques (euthanized at weeks 18, 19 and 20) did not develop cellular or humoral immune responses, whereas the other 3 morphine-exposed and 3 control macaques developed both cellular and humoral immune responses.

KW - AIDS

KW - Indian rhesus macaques

KW - Morphine

KW - SHIV

KW - SIV

UR - http://www.scopus.com/inward/record.url?scp=33748965174&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33748965174&partnerID=8YFLogxK

U2 - 10.1016/j.virol.2006.06.020

DO - 10.1016/j.virol.2006.06.020

M3 - Article

C2 - 16876224

AN - SCOPUS:33748965174

VL - 354

SP - 192

EP - 206

JO - Virology

JF - Virology

SN - 0042-6822

IS - 1

ER -